REQUEST A DEMO
Total
USD $0.00
Search more companies

Akson Padjasek - Krysowski sp. j. (Poland)

Main Activities: Pharmacies and Drug Stores
Full name: Akson Padjasek - Krysowski sp. j. Profile Updated: March 20, 2022
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Akson Padjasek - Krysowski sp. j. is an enterprise in Poland, with the main office in Swietochlowice. The company operates in the Pharmacies and Drug Stores sector. Akson Padjasek - Krysowski sp. j. was incorporated on December 31, 2020. There was a net sales revenue increase of 6.14% reported in Akson Padjasek - Krysowski sp. j.’s latest financial highlights for 2022. Its’ total assets recorded a growth of 4.17%. The enterprise’s net profit margin decreased by 2.39% in 2022.

Headquarters
Ul. Polna 73
Swietochlowice; Slaskie; Postal Code: 41-600

Contact Details: Purchase the Akson Padjasek - Krysowski sp. j. report to view the information.

Website: http://www.akson.pl

Basic Information
Outstanding Shares:
Purchase the Akson Padjasek - Krysowski sp. j. report to view the information.
Incorporation Date:
December 31, 2020
Key Executives
Purchase this report to view the information.
Associate
Purchase this report to view the information.
Associate
Purchase this report to view the information.
Associate
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Akson Padjasek - Krysowski sp. j. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
6.14%
Total operating revenue
4.83%
Operating profit (EBIT)
-44.84%
EBITDA
-34.66%
Net Profit (Loss) for the Period
-38.15%
Total assets
4.17%
Total equity
17.08%
Operating Profit Margin (ROS)
-2.82%
Net Profit Margin
-2.39%
Return on Equity (ROE)
-19.62%
Debt to Equity Ratio
-12.24%
Quick Ratio
0.06%
Cash Ratio
0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?